StockData
BioRestorative Therapies, Inc. logo

BioRestorative Therapies, Inc. (BRTX) stock

BRTXNasdaqServices-Misc Health & Allied Services, NECFiscal year ends December 31
Financials through Q1 FY2026, quarter ended Mar 31, 2026Last filing: 10-Q on May 14, 2026Score 8/30
$1.42−0.07 (-4.70%)

Close on Nov 16, 2026Market cap $36.18MP/E –Yield –

BioRestorative Therapies cash

Cash and short-term investments held at the end of each period.

BioRestorative Therapies's cash was $3.59M at Mar 31, 2026. For fiscal 2025 it was $2.95M, down 72.5% from the year before. Over ten years it grew 33.3% a year on average. The highest annual figure on record is $21.03M in fiscal 2021.

Annual cash

PeriodPeriod endValueChange
FY2025Dec 31, 2025$2.95M-72.5%
FY2024Dec 31, 2024$10.73M-3.0%
FY2023Dec 31, 2023$11.07M-25.0%
FY2022Dec 31, 2022$14.75M-29.9%
FY2021Dec 31, 2021$21.03M+586.1%
FY2020Dec 31, 2020$3.06M+184071.3%
FY2019Dec 31, 2019$1.66K-98.6%
FY2018Dec 31, 2018$117.52K-74.0%
FY2017Dec 31, 2017$451.68K+1319.4%
FY2016Dec 31, 2016$31.82K-80.9%
FY2015Dec 31, 2015$166.56K+81.4%
FY2014Dec 31, 2014$91.80K-54.4%
FY2013Dec 31, 2013$201.10K+55298.9%
FY2012Dec 31, 2012$363-99.5%
FY2011Dec 31, 2011$71.51K+295.6%
FY2010Dec 31, 2010$18.07K+42933.3%
FY2009Dec 31, 2009$42–
FY2008Dec 29, 2008$0–

Quarterly cash

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q1 FY2026Mar 31, 2026$3.59M-60.6%
Q4 FY2025Dec 31, 2025$2.95M-72.5%
Q3 FY2025Sep 30, 2025$4.49M-65.7%
Q2 FY2025Jun 30, 2025$7.38M-49.7%
Q1 FY2025Mar 31, 2025$9.11M-44.5%
Q4 FY2024Dec 31, 2024$10.73M-3.0%
Q3 FY2024Sep 30, 2024$13.09M+6.9%
Q2 FY2024Jun 30, 2024$14.68M+26.4%
Q1 FY2024Mar 31, 2024$16.42M+32.7%
Q4 FY2023Dec 31, 2023$11.07M-25.0%
Q3 FY2023Sep 30, 2023$12.24M-25.8%
Q2 FY2023Jun 30, 2023$11.62M-35.2%
Q1 FY2023Mar 31, 2023$12.37M-36.0%
Q4 FY2022Dec 31, 2022$14.75M-29.9%
Q3 FY2022Sep 30, 2022$16.49M+1359.4%
Q2 FY2022Jun 30, 2022$17.93M+919.5%
Q1 FY2022Mar 31, 2022$19.32M+672.6%
Q4 FY2021Dec 31, 2021$21.03M+586.1%
Q3 FY2021Sep 30, 2021$1.13M+541.9%
Q2 FY2021Jun 30, 2021$1.76M+490.1%
Q1 FY2021Mar 31, 2021$2.50M+52220.3%
Q4 FY2020Dec 31, 2020$3.06M+184071.3%
Q3 FY2020Sep 30, 2020$175.99K+79.4%
Q2 FY2020Jun 30, 2020$298.10K-76.8%
Q1 FY2020Mar 31, 2020$4.78K-99.0%
Q4 FY2019Dec 31, 2019$1.66K-98.6%
Q3 FY2019Sep 30, 2019$98.11K-6.9%
Q2 FY2019Jun 30, 2019$1.28M+36274.8%
Q1 FY2019Mar 31, 2019$496.28K+5694.9%
Q4 FY2018Dec 31, 2018$117.52K-74.0%
Q3 FY2018Sep 30, 2018$105.37K+14256.1%
Q2 FY2018Jun 30, 2018$3.53K+86.6%
Q1 FY2018Mar 31, 2018$8.56K-3.3%
Q4 FY2017Dec 31, 2017$451.68K+1319.4%
Q3 FY2017Sep 30, 2017$734-88.4%
Q2 FY2017Jun 30, 2017$1.89K-99.6%
Q1 FY2017Mar 31, 2017$8.86K–
Q4 FY2016Dec 31, 2016$31.82K–
Q3 FY2016Sep 30, 2016$6.32K–
Q2 FY2016Jun 30, 2016$516.19K–

More BioRestorative Therapies figures

See a number that looks wrong?